Acute-on-chronic liver failure: Excellent outcomes after liver transplantation but high mortality on the wait list

Liver Transplantation

Volumn 19, Issue 8, 2013, Pages 879-886

  Finkenstedt, Armin ^a   Nachbaur, Karin ^a   Zoller, Heinz ^a   Joannidis, Michael ^a   Pratschke, Johann ^a   Graziadei, Ivo W ^a   Vogel, Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; CIPROFLOXACIN; SULTAMICILLIN; TERLIPRESSIN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE ON CHRONIC LIVER FAILURE; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PERITONITIS; BILIRUBIN BLOOD LEVEL; BRAIN EDEMA; BRAIN HEMORRHAGE; CAUSE OF DEATH; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEMORRHAGIC SHOCK; HEPATORENAL SYNDROME; HOSPITAL ADMISSION; HUMAN; INTENTION TO TREAT ANALYSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; OLIGURIA; ORGAN DONOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; SEPSIS; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME;

EID: 84881096312     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23678     Document Type: Article

References (25)

1. Duseja A, Chawla YK, Dhiman RK, Kumar A, Choudhary N, Taneja S,. Non-hepatic insults are common acute precipitants in patients with acute on chronic liver failure (ACLF). Dig Dis Sci 2010; 55: 3188-3192.
2. Juneja D, Gopal PB, Kapoor D, Raya R, Sathyanarayanan M,. Profiles and outcome of patients with liver cirrhosis requiring mechanical ventilation. J Intensive Care Med 2012; 27: 373-378.
3. Katoonizadeh A, Laleman W, Verslype C, Wilmer A, Maleux G, Roskams T, Nevens F,. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut 2010; 59: 1561-1569.
4. Garg H, Kumar A, Garg V, Sharma P, Sharma BC, Sarin SK,. Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure. Dig Liver Dis 2012; 44: 166-171.
5. Sen S, Williams R, Jalan R,. The pathophysiological basis of acute-on-chronic liver failure. Liver 2002; 22 (suppl 2): 5-13.
6. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 2009; 3: 269-282.
7. Chan AC, Fan ST, Lo CM, Liu CL, Chan SC, Ng KK, et al. Liver transplantation for acute-on-chronic liver failure. Hepatol Int 2009; 3: 571-581.
8. Liu CL, Fan ST, Lo CM, Wei WI, Yong BH, Lai CL, Wong J,. Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation 2003; 76: 1174-1179.
9. Chen Z, Wen T, Zeng Y, Wang L, Lu JJ, Gong S, et al. A single institution experience with living donor liver transplantation for acute-on-chronic hepatitis B liver failure. Hepatogastroenterology 2011; 58: 1267-1273.
10. Bahirwani R, Shaked O, Bewtra M, Forde K, Reddy KR,. Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes. Transplantation 2011; 92: 952-957.
11. Mattéi A, Rucay P, Samuel D, Feray C, Reynes M, Bismuth H,. Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration. J Hepatol 1995; 22: 597.
12. Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006; 10: R108.
13. Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, Williams R, Jalan R,. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 2004; 10: 1109-1119.
14. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.
15. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655.
16. Wiest R, Krag A, Gerbes A,. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut 2012; 61: 297-310.
17. Murray KF, Carithers RL Jr,;, for AASLD,. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005; 41: 1407-1432.
18. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al.; for CANONIC Study Investigators of the EASL-CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology; doi: 10. 1053/j.gastro.2013.02. 042.
19. Levesque E, Hoti E, Azoulay D, Ichaï P, Habouchi H, Castaing D, et al. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 2012; 56: 95-102.
20. O'Brien AJ, Welch CA, Singer M, Harrison DA,. Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients. Intensive Care Med 2012; 38: 991-1000.
21. Bone RC,. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24: 1125-1128.
22. Rosenbloom AJ, Pinsky MR, Bryant JL, Shin A, Tran T, Whiteside T,. Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction. JAMA 1995; 274: 58-65.
23. Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghöner A, Vidacek D, Siewert E, et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol 2005; 42: 195-201.
24. Millonig G, Kern M, Ludwiczek O, Nachbaur K, Vogel W,. Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening? World J Gastroenterol 2006; 12: 974-976.
25. Hsieh CY, Huang HH, Lin CY, Chung LW, Liao YM, Bai LY, Chiu CF,. Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma. J Clin Oncol 2008; 26: 2584-2586.